Skip to main content
. 2019 Jul 12;152(3):258–276. doi: 10.1093/ajcp/aqz067

Table 1 .

Features of Cases Submitted With Germline GATA2 Mutation

GATA2 Mutation
Case No. Age, y Sex Genomic Protein Type Familial or Sporadic Infections Other Prior Disease PB Cytopenias Bone Marrow Diagnosis Karyotype NGS Additional Mutations
20 18 M c.821delC p.274fs FS PS F NR Family history of solid tumors No P, blasts AML-MRC –7, +8, add NR
40 17 M c.1081C>T p.R361C M ZF2 NR NR Presented post MVA No Monocytosis CMML –7 ASXL1 R693X, KRAS G12V, STAT3 S614R
48 6 M c.610C>T p.Arg204* PS F NR Megakaryoblasts No P AML-MRC –7 WT1
52 22 F c.1114G>A p.A372T M ZF2 S PNA, cellulitis, cervical HPV Lymphedema Yes P MDS-EB2 –7 NR
87 5 M c.1143 + 200_1198del Lg Del NR cellulitis, warts Lymphedema Yes N, B-NK RCC N ASXL1
105 57 M c.1085G>A p.Arg362Gln M ZF2 F NR Patient was donor for brother with AML 20 y prior Yes P MDS-MLD N NR
138 13 F c.16delG p.6fs FS S NR 2-y prior history of anemia Yes A, N MDS-MLD N NR
157 45 F c.1045T>C p.C349R M ZF2 NR HPV-carcinomas Onset age 16, prior diagnosis of AA Yes P MDS-MLD +21 NR
176 10 F c.154_179del, p.H51fs* FS PS NR NR Lymphedema, onset age 6 Yes N MDS-EB1 –7 ASXL1, NRAS
236 30 M c.706A>G p.Met236Val M VUS F NR BT, pure erythroid leukemia Yes, BT P AML-MRC Complex NR
258 62 F c.1193G>A p.R398Q M ZF2 NR MAI 0nset 52 y cytopenias Yes A, Mo, L HLHBMID +8 NR
266 16 F c.521del p.174fs FS NR NR h/o MDS 1 y prior Yes P AML-MRC N FANC
275 44 F c.1192C>T p.R398W M ZF2 F Pulmonary aspergillosis, MAI, cervical HPV Mother died colon cancer 31 y; sister died 36 y infection; AFB + marrow Yes T, Mo, L BMID N STAG2 p.R614X
307 12 M 3.1-3.3 Mb deletion; nt 128198265-128212030 Lg Del S PNA No A,N,Mo, rare Blasts RCC –7 CRLF2 p.N63S
337 31 F c.1017 + 572C>T R/I F Pannicullitis, PNA, HPV, MAI Granulomata in marrow Yes P, Mo, B, NK MDS-MLD +8 NR
381 17 F c.1084C>T; p.R362* PS ZF2 NR NR No A, N RCC Der(1;7), +8 NR

A, anemia; AA, aplastic anemia; AFB, acid-fast bacilli; AML-MRC, acute myeloid leukemia with myelodysplasia-related changes; B, B-lymphopenia; BMID, bone marrow and immunodeficiency disorder; BT, β-thalassemia; cellu, cellulitis; cerv, cervical; CMML, chronic myelomonocytic leukemia; F, familial; FS, frameshift; HLH, hemophagocytic lymphohistiocytosis; HPV, human papillomavirus; L, lymphopenia; Lg Del, large deletion; M, missense; Mo, monocytopenia; MAI, Mycobacterium avium-intracellulare; MDS-EB1, myelodysplastic syndrome with excess blasts I; MDS-EB2, myelodysplastic syndrome with excess blasts II; MDS-MLD, myelodysplastic syndrome with multilineage dysplasia; MVA, motor vehicle accident; N, neutropenia; NGS, next-generation sequencing; NK, NK-lymphopenia; NR, not reported; P, pancytopenia; PNA, pneumonia; PNA, pneumonia; PS, premature stop; RCC, refractory cytopenia of childhood; R/I, regulatory/intronic; S, sporadic; T, thrombocytopenia; VUS, variant of unknown significance; ZF2, zinc finger 2.